Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Lung Cancer

  Free Subscription


Articles published in Chest

Retrieve available abstracts of 111 articles:
HTML format



Single Articles


    September 2021
  1. SMITH HB, Ward R, Frazier C, Angotti J, et al
    Guideline Recommended Lung Cancer Screening Adherence is Superior with Centralized Approach.
    Chest. 2021 Sep 15. pii: S0012-3692(21)03856-3. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  2. SLATORE CG, Golden SE, Thomas T, Patzel M, et al
    Beliefs and Practices of Primary Care Providers regarding Performing Low-Dose Computed Tomography Studies for Lung Cancer Screening.
    Chest. 2021 Sep 1. pii: S0012-3692(21)03834-4. doi: 10.1016/j.chest.2021.
    PubMed    


    August 2021
  3. SAINZ ZUNIGA PV, Ost DE
    Impact of Delays in Lung Cancer Treatment on Survival.
    Chest. 2021 Aug 20. pii: S0012-3692(21)03689-8. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  4. KUNITOMO Y, Bade B, Gunderson CG, Akgun KM, et al
    Racial Differences in Adherence to Lung Cancer Screening Follow-Up: A Systematic Review and Meta-Analysis.
    Chest. 2021 Aug 11. pii: S0012-3692(21)03664.
    PubMed     Abstract available


  5. VACHANI A, Zheng C, Amy Liu IL, Huang BZ, et al
    The probability of lung cancer in patients with incidentally detected pulmonary nodules: clinical characteristics and accuracy of prediction models.
    Chest. 2021 Aug 5. pii: S0012-3692(21)03624-2. doi: 10.1016/j.chest.2021.07.2168
    PubMed     Abstract available


  6. ZELIADT SB
    Smoking Cessation Resources Can and Should Be Integrated in Lung Cancer Screening.
    Chest. 2021;160:413-414.
    PubMed    


    July 2021
  7. TANDJAOUI-LAMBIOTTE Y, Akrour Y, Gibelin A, Gonzalez F, et al
    Tyrosine kinase inhibitors for acute respiratory failure due to non-small-cell lung cancer involvement in intensive care unit.
    Chest. 2021 Jul 21. pii: S0012-3692(21)01358-1. doi: 10.1016/j.chest.2021.
    PubMed    


  8. FEDEWA SA, Bandi P, Smith RA, Silvestri GA, et al
    Lung Cancer Screening Rates During the COVID-19 Pandemic.
    Chest. 2021 Jul 20. pii: S0012-3692(21)01364-7. doi: 10.1016/j.chest.2021.
    PubMed    


  9. VAKIL E, Jackson N, Sainz-Zunega PV, Molina S, et al
    Optimizing diagnostic and staging pathways for suspected lung cancer: a decision analysis.
    Chest. 2021 Jul 10. pii: S0012-3692(21)01314-3. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  10. MAZZONE PJ, Silvestri GA, Souter LH, Caverly TJ, et al
    Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.
    Chest. 2021 Jul 9. pii: S0012-3692(21)01307-6. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  11. MAZZONE PJ, Silvestri GA, Souter LH, Caverly TJ, et al
    Screening for Lung Cancer: CHEST Guideline and Expert Panel Report - Executive Summary.
    Chest. 2021 Jul 9. pii: S0012-3692(21)01304-0. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  12. BUEHLER KE, Wilshire CL, Gilbert CR, Gorden JA, et al
    Imaging Administrators: The Overlooked Barrier to Lung Cancer Screening Implementation.
    Chest. 2021 Jul 9. pii: S0012-3692(21)01313-1. doi: 10.1016/j.chest.2021.
    PubMed    


  13. PASQUINELLI MM, Tammemagi MC, Kovitz KL, Durham ML, et al
    Addressing Gender Disparities in Lung Cancer Screening Eligibility: USPSTF versus PLCOm2012 Criteria.
    Chest. 2021 Jul 9. pii: S0012-3692(21)01316-7. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  14. SEARS CR, Rivera MP
    Age, Sex, Smoking, and Race: Is Progress Being Made in Lung Cancer Screening Eligibility?
    Chest. 2021;160:31-33.
    PubMed    


    June 2021
  15. FOX AH, Jett JR, Roy UB, Johnson BE, et al
    Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-Small Cell Lung Cancer.
    Chest. 2021 Jun 25. pii: S0012-3692(21)01253-8. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  16. GUINDE J, Bourdages-Pageau E, Collin-Castonguay MM, Laflamme L, et al
    A Prediction Model to Optimize Invasive Mediastinal Staging Procedures for Non-Small Cell Lung Cancer in Patients with a Radiologically Normal Mediastinum: the Quebec Prediction Model.
    Chest. 2021 Jun 10. pii: S0012-3692(21)01103-X. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  17. LAMPRIDIS S
    Differences in Staging and Treating Patients With Locally Advanced Non-small Cell Lung Cancer.
    Chest. 2021;159:2518-2519.
    PubMed    


    May 2021
  18. FARJAH F, Tanner NT
    How I Do It: Mediastinal Staging for Lung Cancer.
    Chest. 2021 May 21. pii: S0012-3692(21)00900-4. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  19. LI F, Yuan L, Zhao Y, Wang S, et al
    Comparison of two proposed changes to the current nodal classification for non-small cell lung cancer based on the number and ratio of metastatic lymph nodes.
    Chest. 2021 May 21. pii: S0012-3692(21)00907-7. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  20. VIGNERON C, Charpentier J, Wislez M, Mira JP, et al
    Short-term and long-term outcomes of patients with lung cancer and life-threatening complications.
    Chest. 2021 May 4. pii: S0012-3692(21)00864-3. doi: 10.1016/j.chest.2021.
    PubMed    


  21. GOTO T
    Women Fare Better After Lung-Cancer Surgery: What Does This Mean for Clinical Practice?
    Chest. 2021;159:2119-2120.
    PubMed    


  22. MACROSTY CR, Rivera MP
    Increased Risk and Improved Survival: The Double-Edged Sword of Lung Cancer in Women.
    Chest. 2021;159:1719-1720.
    PubMed    


  23. MASCALCHI M, Luconi M
    Lung Cancer Screening, Emphysema, and COPD.
    Chest. 2021;159:1699-1700.
    PubMed    


  24. SCHARNETZKI L, Schiller JH
    Lung Cancer: Why the Stigma? And What Can Be Done?
    Chest. 2021;159:1721-1722.
    PubMed    


    April 2021
  25. MARTINEZ-ZAYAS G, Almeida FA, Yarmus L, Steinfort D, et al
    Predicting Lymph Node Metastasis in Non-Small Cell Lung Cancer: Prospective External and Temporal Validation of the HAL and HOMER Models.
    Chest. 2021 Apr 28. pii: S0012-3692(21)00856-4. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  26. RIVERA MP, Charlot M, Durham DD, Throneburg A, et al
    Molecular Biomarker and Program Death-Ligand 1 Expression Testing in Patients with Advanced Stage Non-Small Cell Lung Cancer Across North Carolina Community Hospitals.
    Chest. 2021 Apr 19. pii: S0012-3692(21)00702-9. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  27. ROOSAN MR, Mambetsariev I, Pharaon R, Fricke J, et al
    Utility of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients with Non-small Cell Lung Cancer.
    Chest. 2021 Apr 17. pii: S0012-3692(21)00705-4. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  28. RAJARAM R
    Hospital Variation in Long-Term Survival After Lung Cancer Surgery.
    Chest. 2021;159:1330-1331.
    PubMed    


  29. LONG JM
    Cutting Corners in the Mediastinum: Should Contralateral Hilar N3 Nodes Be Omitted From Staging?
    Chest. 2021;159:1328-1329.
    PubMed    


  30. BENZAQUEN S, Kaini N, Gupta E, Litwin D, et al
    Women Presenting With Asthma and Persistent Wheezing: A Case Series.
    Chest. 2021;159:e267-e275.
    PubMed    


  31. STERN KM, Ries S, Beltran A, Youssef FA, et al
    A 51-Year-Old Woman With Rapidly Progressive Dyspnea.
    Chest. 2021;159:e251-e255.
    PubMed     Abstract available


  32. ROY AM, Venkata AN, Yadala S
    A 44-Year-Old Woman With a 10-Year History of Dyspnea and Pulmonary Nodules.
    Chest. 2021;159:e247-e250.
    PubMed     Abstract available


  33. IDO F, Purdy A, Harrison MA, Longo S, et al
    Shortness of Breath in a 38-Year-Old Woman With Pulmonary and Hepatic Nodules.
    Chest. 2021;159:e261-e266.
    PubMed     Abstract available


  34. SAINZ ZUNIGA PV, Martinez-Zayas G, Molina S, Grosu HB, et al
    Is Biopsy of Contralateral Hilar N3 Lymph Nodes With Negative PET-CT Scan Findings Necessary When Performing Endobronchial Ultrasound Staging?
    Chest. 2021;159:1642-1651.
    PubMed     Abstract available


    March 2021
  35. LIANG RB, Li P, Li BT, Jin JT, et al
    Modification of Pathological T Classification for Non-small Cell Lung Cancer with Visceral Pleural Invasion: Data from 1,055 Cases of Cancers 3 cm or Less.
    Chest. 2021 Mar 18. pii: S0012-3692(21)00500-6. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  36. GIANLUCA M, Federica S, Stefano S, Eufrasia LR, et al
    FEASIBILITY AND SAFETY OF LUNG CANCER SCREENING AND PREVENTION PROGRAM DURING THE COVID-19 PANDEMIC.
    Chest. 2021 Mar 18. pii: S0012-3692(21)00503-1. doi: 10.1016/j.chest.2021.
    PubMed    


  37. SHEN J, Crothers K, Kross EK, Petersen K, et al
    Provision of Smoking Cessation Resources in the Context of in-person Shared Decision Making for Lung Cancer Screening.
    Chest. 2021 Mar 18. pii: S0012-3692(21)00493-1. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  38. TAJARERNMUANG P, Ofiara L, Beaudoin S, Wang H, et al
    Real-world outcomes of patients with advanced non-small cell lung cancer treated with anti-PD1 therapy on the basis of PD-L1 Results in EBUS-TBNA vs. histological specimens.
    Chest. 2021 Mar 3. pii: S0012-3692(21)00453-0. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  39. TURNER J, Pond GR, Tremblay A, Johnston M, et al
    Risk Perception Among a Lung Cancer Screening Population.
    Chest. 2021 Mar 2. pii: S0012-3692(21)00450-5. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  40. CHONG WH, Ibrahim A, Saha BK
    A 69-Year-Old Woman With Ulcerative Colitis and Pulmonary Nodules.
    Chest. 2021;159:e147-e150.
    PubMed     Abstract available


  41. SUNDARAM V, Gould MK, Nair VS
    A Comparison of the PanCan Model and Lung-RADS to Assess Cancer Probability Among People With Screening-Detected, Solid Lung Nodules.
    Chest. 2021;159:1273-1282.
    PubMed     Abstract available


  42. ZHANG Y, Deng C, Fu F, Ma Z, et al
    Excellent Prognosis of Patients With Invasive Lung Adenocarcinomas During Surgery Misdiagnosed as Atypical Adenomatous Hyperplasia, Adenocarcinoma In Situ, or Minimally Invasive Adenocarcinoma by Frozen Section.
    Chest. 2021;159:1265-1272.
    PubMed     Abstract available


  43. TANNER NT, Springmeyer SC, Porter A, Jett JR, et al
    Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules: Extended Analyses and 2-Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial.
    Chest. 2021;159:1283-1287.
    PubMed    


    February 2021
  44. ATCHLEY WT, Alvarez C, Saxena-Beem S, Schwartz TA, et al
    Immune checkpoint inhibitor-related pneumonitis in lung cancer: real-world incidence, risk factors, and management practices across six health care centers in North Carolina.
    Chest. 2021 Feb 20. pii: S0012-3692(21)00340-8. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  45. BOUDREAU JH, Miller DR, Qian S, Nunez ER, et al
    Access to lung cancer screening in the Veterans Health Administration: Does geographic distribution match need in the population?
    Chest. 2021 Feb 19. pii: S0012-3692(21)00280-4. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  46. NISHI SPE, Lowenstein LM, Mendoza TR, Lopez Olivo MA, et al
    Shared Decision Making for Lung Cancer Screening: How Well are we "Sharing"?
    Chest. 2021 Feb 5. pii: S0012-3692(21)00115-X. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  47. PINSKY PF, Lau YK, Doubeni CA
    Potential Disparities by Sex and Race-ethnicity in Lung Cancer Screening Eligibility Rates.
    Chest. 2021 Feb 2. pii: S0012-3692(21)00232-4. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  48. MAZZONE PJ, Thomson CC, Kazerooni EA, Smith RA, et al
    Proposed Quality Metrics for Lung Cancer Screening Programs: A National Lung Cancer Roundtable Project.
    Chest. 2021 Feb 1. pii: S0012-3692(21)00223-3. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  49. ZHOU K, Che G
    The Surgical Approach and Duration of Surgery Should Be Considered in Statistical Models for the Analysis of Postoperative Complications in Patients With Resected Lung Cancer.
    Chest. 2021;159:886-887.
    PubMed    


  50. HUI SLY, Haja Mohideen SM, Cheng XM, Chew SY, et al
    Chronic Cough With Non-Resolving Mass-like Consolidation.
    Chest. 2021;159:e119-e126.
    PubMed     Abstract available


  51. CHUAN TY, Mun WL, Siang WH
    An 86-Year-Old Woman Presenting With 2 Weeks of Worsening Dyspnea and Cough.
    Chest. 2021;159:e103-e106.
    PubMed     Abstract available


  52. CHEN AC, Pastis NJ Jr, Mahajan AK, Khandhar SJ, et al
    Robotic Bronchoscopy for Peripheral Pulmonary Lesions: A Multicenter Pilot and Feasibility Study (BENEFIT).
    Chest. 2021;159:845-852.
    PubMed     Abstract available


    January 2021
  53. HENDERSON LM, Benefield T, Bosemani T, Long JM, et al
    Impact of the COVID-19 pandemic on volumes and disparities in lung cancer screening.
    Chest. 2021 Jan 5. pii: S0012-3692(20)35527-6. doi: 10.1016/j.chest.2020.
    PubMed    


  54. DENG HY, Tang X, Zhou Q
    How to Select Patients With Clinically Early-Stage Non-Small Cell Lung Cancer for Segmentectomy?
    Chest. 2021;159:444-445.
    PubMed    


  55. KHANNA VK, Ghosh S, MacMahon H, Mehta AC, et al
    Criteria for Low-Dose CT Lung Cancer Screening in the Setting of Air Pollution: A Discussion That Is Long Overdue.
    Chest. 2021;159:42-45.
    PubMed    


  56. MYERS RE
    Health Organizations Have an Opportunity to Improve Shared Decision-Making and Raise Lung Cancer Screening Rates.
    Chest. 2021;159:23-24.
    PubMed    


  57. ROMAN MA, Nakas A
    Comparing Outcomes of Segmentectomy and Lobectomy for Non-small Cell Lung Cancer: Is Less Truly More?
    Chest. 2021;159:21-22.
    PubMed    


  58. ENDICOTT-YAZDANI TR, Baird RW, Koch MS, Moore AJ, et al
    A 55-Year-Old Woman With Frequent Pulmonary Exacerbations and Endobronchial Lesions.
    Chest. 2021;159:e49-e52.
    PubMed     Abstract available


  59. MAYER N, Carboni GL, Thielken A, Wagnetz D, et al
    Sclerosing Pneumocytoma: A Host for a Typical Carcinoid With Pleural Metastasis-A Wolf in Sheep`s Clothing.
    Chest. 2021;159:e1-e5.
    PubMed     Abstract available


  60. DUCOMB EA, Kinsey CM
    Response.
    Chest. 2021;159:447-448.
    PubMed    


  61. ROY P, Fortin M
    Should We Expand Invasive Mediastinal Staging to Peripheral T1 Lung Tumors?
    Chest. 2021;159:446-447.
    PubMed    


  62. RAMAN V, Jawitz OK, D'Amico TA, Yang CJ, et al
    Response.
    Chest. 2021;159:445-446.
    PubMed    


  63. ABOUDARA M, Rickman OB, Maldonado F
    An Evaluation of Bronchoscopy Diagnostic Yield: Should We Only Be Doing EBUS?
    Chest. 2021;159:437-438.
    PubMed    


  64. ALMQUIST DR, Sonbol MB, Ross HJ, Kosiorek H, et al
    Clinical Characteristics of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: A Retrospective Analysis.
    Chest. 2021;159:432-434.
    PubMed    


  65. LEE HJ, Mazzone P, Feller-Kopman D, Yarmus L, et al
    Impact of the Percepta Genomic Classifier on Clinical Management Decisions in a Multicenter Prospective Study.
    Chest. 2021;159:401-412.
    PubMed     Abstract available


    December 2020
  66. XU L, Su H, She Y, Dai C, et al
    Which N descriptor is more predictive of prognosis in resected non-small cell lung cancer: the number of involved nodal stations versus the location-based pathological N stage?
    Chest. 2020 Dec 19. pii: S0012-3692(20)35457-X. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  67. BANERJEE SC, Haque N, Schofield EA, Williamson TJ, et al
    Oncology Care Provider (OCP) Training in Empathic Communication Skills to Reduce Lung Cancer Stigma.
    Chest. 2020 Dec 15. pii: S0012-3692(20)35308-3. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  68. LABAKI WW, Xia M, Murray S, Hatt CR, et al
    Quantitative Emphysema on Low-Dose Computed Tomography of the Chest and Risk of Lung Cancer and Airflow Obstruction: An analysis of the National Lung Screening Trial.
    Chest. 2020 Dec 13. pii: S0012-3692(20)35356-3. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  69. LIU L, Rwigema JN, Song Z, Cockburn M, et al
    Assessing Disparities in Lung Cancer Incidence for Gender Minority Individuals Using California Cancer Registry Data.
    Chest. 2020 Dec 4. pii: S0012-3692(20)35328-9. doi: 10.1016/j.chest.2020.
    PubMed    


  70. CLEVEN KL, Vaeth B, Zeig-Owens R, Colbeth HL, et al
    Performance of Risk factor-based Guidelines and Model-based Chest CT Lung Cancer Screening in World Trade Center Exposed Fire Department Rescue/Recovery Workers.
    Chest. 2020 Dec 3. pii: S0012-3692(20)35314-9. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  71. JIM YEUNG SC, Elsayem A
    Early Palliative Care for Patients With Advanced Lung Cancer: Opportunities in the ED.
    Chest. 2020;158:2266-2267.
    PubMed    


    November 2020
  72. SACHS E, Sartipy U, Jackson V
    Sex and survival after surgery for lung cancer: A Swedish nationwide cohort.
    Chest. 2020 Nov 17. pii: S0012-3692(20)35155-2. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  73. SCHWALK AJ, Ost DE, Saltijeral SN, De La Garza H, et al
    Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients with Metastatic Non-Small Cell Lung Cancer with EGFR or ALK Mutations.
    Chest. 2020 Nov 17. pii: S0012-3692(20)35151-5. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  74. OSAROGIAGBON RU, Sineshaw HM, Lin CC, Jemal A, et al
    Institution-level differences in quality and outcomes of lung cancer resections in the United States.
    Chest. 2020 Nov 13. pii: S0012-3692(20)35134-5. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  75. YOUNG RP, Hopkins RJ, Gamble GD, Silvestri GA, et al
    Incorporating baseline lung function in lung cancer screening: Does a "lung health check" help predict outcomes?
    Chest. 2020 Nov 7. pii: S0012-3692(20)35129-1. doi: 10.1016/j.chest.2020.
    PubMed    


    October 2020
  76. LANG M, Yeung T, Shepard JO, Sharma A, et al
    Operational challenges of a low-dose CT lung cancer screening program during the COVID-19 pandemic.
    Chest. 2020 Oct 26. pii: S0012-3692(20)35095-9. doi: 10.1016/j.chest.2020.
    PubMed    


  77. KUNITOMO Y, Young G, Datta R, Korn LL, et al
    A 62-Year-Old Woman With Lung Cancer, Ulcerating Rash, and Rapidly Progressive Hypoxemia.
    Chest. 2020;158:e191-e196.
    PubMed     Abstract available



  78. Correction to Text in: Lung Cancer Screening Uptake in the United States.
    Chest. 2020;158:1797.
    PubMed    


  79. BRAILLON A
    Lung Cancer Screening: No Shared Decision-making When Overlooking Carl Rogers.
    Chest. 2020;158:1795-1796.
    PubMed    


  80. YANG H, Hall SRR, Yao F
    The Value of PD-L1 Expression in Metastatic Lymph Nodes of Advanced Non-Small Cell Lung Cancer.
    Chest. 2020;158:1785-1787.
    PubMed    


  81. SPRINGMEYER SC, Jett J, Bhadra K, Kheir F, et al
    Managing Lung Nodules Using Telemedicine and Molecular Biomarkers During the COVID-19 Pandemic.
    Chest. 2020;158:1794-1795.
    PubMed    


    September 2020
  82. CAVERLY TJ, Zhang X, Hayward RA, Zhu J, et al
    Effects of Random Measurement Error on Lung Cancer Screening Decisions:: A Retrospective-Cohort-Based Microsimulation Study.
    Chest. 2020 Sep 14. pii: S0012-3692(20)34491.
    PubMed     Abstract available


  83. DUNCAN FC, Sears CR
    Patient Perspectives on Shared Decision-Making in Lung Cancer Screening: To Teach or To Trust?
    Chest. 2020;158:860-861.
    PubMed    


  84. SAHAR L, Douangchai Wills VL, Liu KK, Kazerooni EA, et al
    Using Geospatial Analysis to Evaluate Access to Lung Cancer Screening in the United States.
    Chest. 2020 Sep 1. pii: S0012-3692(20)34311-7. doi: 10.1016/j.chest.2020.08.2081
    PubMed     Abstract available


    August 2020
  85. SINGHVI D, Bon J
    Computed Tomography Imaging and Comorbidities in Chronic Obstructive Pulmonary Disease: Beyond Lung Cancer Screening.
    Chest. 2020 Aug 21. pii: S0012-3692(20)34274.
    PubMed     Abstract available


  86. GIERADA DS, Pinsky PF
    Survival After Detection of Stage I Lung Cancer by Screening in the National Lung Screening Trial.
    Chest. 2020 Aug 18. pii: S0012-3692(20)34234.
    PubMed     Abstract available


  87. TABRIZ AA, Neslund-Dudas C, Turner K, Rivera MP, et al
    How Health Care Organizations Implement Shared Decision Making When It Is Required for Reimbursement: The Case of Lung Cancer Screening.
    Chest. 2020 Aug 13. pii: S0012-3692(20)32191-7. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


    July 2020
  88. HOEIJMAKERS F, Heineman DJ, Daniels JM, Beck N, et al
    Variation between multidisciplinary tumor boards in clinical staging and treatment recommendations for patients with locally advanced non-small cell lung cancer.
    Chest. 2020 Jul 29. pii: S0012-3692(20)32079-1. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  89. RAMAN V, Jawitz OK, Voigt SL, Rhodin KE, et al
    The Effect of Tumor Size and Histology on Outcomes Following Segmentectomy vs. Lobectomy for Clinically Node-negative Non-small Cell Lung Cancer.
    Chest. 2020 Jul 8. pii: S0012-3692(20)31868-7. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  90. FUKUNAGA MI, Halligan K, Kodela J, Toomey S, et al
    Tools to promote shared decision making in lung cancer screening using low-dose computerized tomography: a systematic review.
    Chest. 2020 Jul 3. pii: S0012-3692(20)31846-8. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


    June 2020
  91. TANNER NT, Thomas NA, Ward R, Rojewski A, et al
    Association of Cigarette Type and Nicotine Dependence in Patients Presenting for Lung Cancer Screening.
    Chest. 2020 Jun 27. pii: S0012-3692(20)31822-5. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  92. VRANAS KC, Lapidus JA, Ganzini L, Slatore CG, et al
    Association of Palliative Care Use and Setting with Healthcare Utilization and Quality of Care at the End of Life Among Patients with Advanced Lung Cancer.
    Chest. 2020 Jun 23. pii: S0012-3692(20)31721-9. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  93. TAILOR TD, Tong BC, Gao J, Henderson LM, et al
    Utilization of Lung Cancer Screening in the Medicare Fee-for-Service Population.
    Chest. 2020 Jun 17. pii: S0012-3692(20)31674-3. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  94. URBANIA TH, Dusendang JR, Herrinton LJ, Alexeeff S, et al
    Standardized reporting and management of suspicious findings on chest computed tomography is associated with improved lung cancer diagnosis in an observational study.
    Chest. 2020 Jun 17. pii: S0012-3692(20)31677-9. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  95. SAGAR AS, Sabath BF, Eapen GA, Song J, et al
    "Incidence and Location of Atelectasis Developed During Bronchoscopy Under General Anesthesia" (I-LOCATE Trial).
    Chest. 2020 Jun 16. pii: S0012-3692(20)31632-9. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


    May 2020
  96. THOMAS A, Mian I, Tlemsani C, Pongor L, et al
    CLINICAL AND GENOMIC CHARACTERISTICS OF SMALL CELL LUNG CANCER IN NEVER-SMOKERS: RESULTS FROM A RETROSPECTIVE MULTICENTER COHORT STUDY.
    Chest. 2020 May 25. pii: S0012-3692(20)31504-X. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  97. FOLCH EE, Labarca G, Ospina-Delgado D, Kheir F, et al
    Sensitivity and Safety of Electromagnetic Navigation Bronchoscopy for Lung Cancer Diagnosis: Systematic Review and Meta-analysis.
    Chest. 2020 May 22. pii: S0012-3692(20)31502-6. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  98. TANNER NT, Brasher PB, Wojciechowski B, Ward R, et al
    Screening Adherence in the Veterans Administration Lung Cancer Screening Demonstration Project.
    Chest. 2020 May 18. pii: S0012-3692(20)31414-8. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  99. PERROTTA F, Nankivell M, Adizie B, Maqsood U, et al
    Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for PD-L1 Testing In Non-Small Cell Lung Cancer.
    Chest. 2020 May 16. pii: S0012-3692(20)31410-0. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  100. RAY MA, Faris NR, Derrick A, Smeltzer MP, et al
    Rurality, Stage-Stratified Use of Treatment Modalities and Survival of Non-small Cell Lung Cancer.
    Chest. 2020 May 6. pii: S0012-3692(20)30868-0. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  101. WIENER RS, Clark JA, Koppelman E, Bolton R, et al
    Patient versus Clinician Perspectives on Communication about Results of Lung Cancer Screening: A Qualitative Study.
    Chest. 2020 May 6. pii: S0012-3692(20)30860-6. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


    April 2020
  102. MAZZONE PJ, Gould MK, Arenberg DA, Chen AC, et al
    Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report.
    Chest. 2020 Apr 22. pii: S0012-3692(20)30758-3. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  103. GOLDEN SE, Ono SS, Melzer A, Davis J, et al
    "I already know that smoking ain't good for me": Patient and clinician perspectives on lung cancer screening decision-making discussions as a teachable moment.
    Chest. 2020 Apr 15. pii: S0012-3692(20)30688-7. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  104. GOLDEN SE, Ono SS, Thakurta SG, Wiener RS, et al
    "I'm putting my trust in their hands": A qualitative study of patients' views on clinician initial communication about lung cancer screening.
    Chest. 2020 Apr 9. pii: S0012-3692(20)30592-4. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  105. VERDIAL FC, Madtes DK, Cheng GS, Pipavath S, et al
    Multidisciplinary Team-Based Management of Incidentally Detected Lung Nodules.
    Chest. 2020;157:985-993.
    PubMed     Abstract available


    March 2020
  106. GIBIER JB, Colombat M, Grardel N, de Charette M, et al
    An 80-Year-Old Woman With a Solitary Pulmonary Nodule.
    Chest. 2020;157:e85-e89.
    PubMed     Abstract available


  107. GRUDEN JF, Naidich DP, Machnicki SC, Cohen SL, et al
    An Algorithmic Approach to the Interpretation of Diffuse Lung Disease on Chest CT Imaging: A Theory of Almost Everything.
    Chest. 2020;157:612-635.
    PubMed     Abstract available


  108. WAHIDI MM, Herth FJF, Chen A, Cheng G, et al
    State of the Art: Interventional Pulmonology.
    Chest. 2020;157:724-736.
    PubMed     Abstract available


  109. VERDIAL FC, Berfield KS, Wood DE, Mulligan MS, et al
    Safety and Costs of Endobronchial Ultrasound-Guided Nodal Aspiration and Mediastinoscopy.
    Chest. 2020;157:686-693.
    PubMed     Abstract available


    February 2020
  110. ABRAMIAN O, Singhal S, Stephen MJ
    A 49-Year-Old Man With Cough and Hand, Wrist, and Knee Pain.
    Chest. 2020;157:e47-e51.
    PubMed     Abstract available


  111. MITCHELL MA, Dhaliwal I, Mulpuru S, Amjadi K, et al
    Early Readmission to Hospital in Patients With Cancer With Malignant Pleural Effusions: Analysis of the Nationwide Readmissions Database.
    Chest. 2020;157:435-445.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: